Scarica l'app Stockscreener
1.04
33.13%
0.2588
Femasys Inc Borsa (FEMY) Ultime notizie
Applying Elliott Wave Theory to Femasys Inc.Trade Entry Summary & Fast Gain Stock Trading Tips - newser.com
Femasys Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Femasys Secures $12 Million Through Private Placement - TipRanks
[8-K] FEMASYS INC Reports Material Event | FEMY SEC FilingForm 8-K - Stock Titan
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Why Femasys Inc. stock is considered a top pick2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Combining machine learning predictions for Femasys Inc.Market Rally & Weekly Market Pulse Updates - newser.com
Can Femasys Inc. stock reach $100 price targetEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Is Femasys Inc. stock a safe haven assetEarnings Beat & AI Enhanced Trading Signals - newser.com
Is Femasys Inc. stock affected by interest rate hikesMarket Risk Summary & Daily Market Momentum Tracking - newser.com
What Wall Street predicts for Femasys Inc. stock price2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Applying Wyckoff theory to Femasys Inc. stockJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Is Femasys Inc. trending in predictive chart modelsRate Hike & Verified Chart Pattern Signals - newser.com
Will Femasys Inc. stock continue upward momentumQuarterly Market Review & Community Consensus Trade Signals - newser.com
How resilient is Femasys Inc. stock in market downturns2025 Buyback Activity & Safe Capital Investment Plans - fcp.pa.gov.br
Does Femasys Inc. show high probability of reboundJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
How analysts rate Femasys Inc. stock todayJuly 2025 Trade Ideas & Verified Short-Term Plans - fcp.pa.gov.br
Exit strategy if you’re trapped in Femasys Inc.Weekly Loss Report & Consistent Return Strategy Ideas - newser.com
Is Femasys Inc. forming a bottoming baseQuarterly Growth Report & Expert Curated Trade Setups - newser.com
MSN Money - MSN
Femasys secures FDA approval to advance final FemBloc trial phase - MSN
Will Femasys Inc. stock benefit from commodity pricesEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
What margin trends mean for Femasys Inc. stockTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
What to do if you’re stuck in Femasys Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com Australia
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN
Femasys surges on Fembloc FDA approval, $58 million funding news | Tap to know more | Inshorts - Inshorts
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Femasys (FEMY) Skyrockets on Breakthrough Birth Control Trial News – Is This Women’s Health Innovator a Game-Changer? - ts2.tech
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - The Manila Times
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys (NASDAQ: FEMY) to issue $12M notes; warrants lift total potential to $58M - Stock Titan
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
0.11%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):